These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. A simple liquid chromatography linked to tandem mass spectrometry method for measurement of serum cholinesterase activity using succinylcholine as substrate. Spencer JD; Rushton D; Allen KR Ann Clin Biochem; 2010 May; 47(Pt 3):217-22. PubMed ID: 20392750 [TBL] [Abstract][Full Text] [Related]
24. Atypical cholinesterase in a psychotic patient with eclampsia. Amaranath L; Hur D; Eastwood DW; Anton AH Am J Obstet Gynecol; 1979 Jan; 133(1):105-6. PubMed ID: 760525 [No Abstract] [Full Text] [Related]
25. Plasma cholinesterase deficiency in a neonate. Pasquariello CA; Schwartz RE Can J Anaesth; 1993 Jun; 40(6):529-31. PubMed ID: 8403119 [TBL] [Abstract][Full Text] [Related]
26. The interrelationship of succinylcholine and the blood cholinesterases during anesthesia. BORDERS RW; STEPHEN CR; NOWILL WK; MARTIN R Anesthesiology; 1955 May; 16(3):401-22. PubMed ID: 14362062 [No Abstract] [Full Text] [Related]
27. [Plasma cholinesterase and abnormal reaction to suxamethonium injection. 20-year experience with the Danish Cholinesterase Registry]. Jensen FS; Mogensen JV Ugeskr Laeger; 1996 Mar; 158(13):1835-9. PubMed ID: 8650760 [TBL] [Abstract][Full Text] [Related]
28. Administration of succinylcholine for electroconvulsive therapy after organophosphate poisoning: a case study. Dillard M; Webb J AANA J; 1999 Dec; 67(6):513-7. PubMed ID: 10876443 [TBL] [Abstract][Full Text] [Related]
29. Plasma cholinesterase activity and neuromuscular paralysis by succinylcholine. Kelemen MH; Volle RL Arch Int Pharmacodyn Ther; 1966 Feb; 159(2):477-83. PubMed ID: 5916749 [No Abstract] [Full Text] [Related]
30. [Effect of a human plasma cholinesterase preparation on the phase II block by succinylcholine]. Hashimoto Y; Shima T; Matsukawa S; Iwatsuki K Masui; 1977 Jun; 26(6):629-32. PubMed ID: 561200 [No Abstract] [Full Text] [Related]
32. Preoperative serum cholinesterase concentration in chronic renal failure. Clinical experience of suxamethonium in 81 patients undergoing renal transplant. Ryan DW Br J Anaesth; 1977 Sep; 49(9):945-9. PubMed ID: 911595 [TBL] [Abstract][Full Text] [Related]
33. Sexamethonium and serum cholinesterase. Comparative studies in vitro and in vivo on the catabolism of suxamethonium. Doenicke A; Schmidinger S; Krumey I Br J Anaesth; 1968 Nov; 40(11):834-44. PubMed ID: 5704352 [No Abstract] [Full Text] [Related]
36. A pharmacogenetic study of a family exhibiting atypical and "silent" genes for plasma cholinesterase. Ernst EA; Smith JC Anesthesiology; 1967; 28(6):1085-9. PubMed ID: 6054213 [No Abstract] [Full Text] [Related]
37. THE DEVELOPING MOTOR END-PLATE: PHARMACOLOGICAL STUDIES IN THE CHICK EMBRYO. DRACHMAN DB J Physiol; 1963 Dec; 169(4):707-12. PubMed ID: 14103555 [No Abstract] [Full Text] [Related]
38. Plasma cholinesterase activity and tachyphylaxis during prolonged succinylcholine infusion. Delisle S; Lebrun M; Bevan DR Anesth Analg; 1982 Nov; 61(11):941-4. PubMed ID: 7137612 [TBL] [Abstract][Full Text] [Related]
39. Effects of neostigmine and pyridostigmine on duration of succinylcholine action and pseudocholinesterase activity. Sunew KY; Hicks RG Anesthesiology; 1978 Sep; 49(3):188-91. PubMed ID: 686441 [No Abstract] [Full Text] [Related]